Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 20 of 24

1.

Persistence of Supplemented Bifidobacterium longum subsp. infantis EVC001 in Breastfed Infants.

Frese SA, Hutton AA, Contreras LN, Shaw CA, Palumbo MC, Casaburi G, Xu G, Davis JCC, Lebrilla CB, Henrick BM, Freeman SL, Barile D, German JB, Mills DA, Smilowitz JT, Underwood MA.

mSphere. 2017 Dec 6;2(6). pii: e00501-17. doi: 10.1128/mSphere.00501-17. eCollection 2017 Nov-Dec.

2.

Dynamics of salivary cortisol in chronic kidney disease patients at stages 1 through 4.

Cardoso EM, Arregger AL, Budd D, Zucchini AE, Contreras LN.

Clin Endocrinol (Oxf). 2016 Aug;85(2):313-9. doi: 10.1111/cen.13023. Epub 2016 Feb 18.

PMID:
26800302
3.

Screening for primary aldosteronism in an argentinian population: a multicenter prospective study.

Leal Reyna M, Gómez RM, Lupi SN, Belli SH, Fenili CA, Martínez MS, Ruibal GF, Rossi MA, Chervin RA, Cornaló D, Contreras LN, Costa L, Nofal MT, Damilano SA, Pardes EM.

Arch Endocrinol Metab. 2015 Oct;59(5):441-7. doi: 10.1590/2359-3997000000075. Epub 2015 Jul 24.

4.

Adrenocortical function in hypotensive patients with end stage renal disease.

Arregger AL, Cardoso EM, Zucchini A, Aguirre EC, Elbert A, Contreras LN.

Steroids. 2014 Jun;84:57-63. doi: 10.1016/j.steroids.2014.03.008. Epub 2014 Mar 28.

PMID:
24686207
5.

An accurate, non-invasive approach to diagnose Cushing's syndrome in at-risk populations.

Cardoso EM, Arregger AL, Monardes G, Contreras LN.

Steroids. 2013 May;78(5):476-82. doi: 10.1016/j.steroids.2013.02.005. Epub 2013 Feb 26.

PMID:
23485687
6.

Hormonal secretion and quality of life in Nelson syndrome and Cushing disease after long acting repeatable octreotide: a short series and update.

Arregger AL, Cardoso EM, Sandoval OB, Monardes Tumilasci EG, Sanchez R, Contreras LN.

Am J Ther. 2014 Jul-Aug;21(4):e110-6. doi: 10.1097/MJT.0b013e318255bc07.

PMID:
22820717
7.

Salivary testosterone for the diagnosis of androgen deficiency in end-stage renal disease.

Cardoso EM, Contreras LN, Tumilasci EG, Elbert A, Aguirre EC, Aquilano DR, Arregger AL.

Nephrol Dial Transplant. 2011 Feb;26(2):677-83. doi: 10.1093/ndt/gfq439. Epub 2010 Jul 20.

PMID:
20659904
8.

Assessment of salivary urea as a less invasive alternative to serum determinations.

Cardoso EM, Arregger AL, Tumilasci OR, Elbert A, Contreras LN.

Scand J Clin Lab Invest. 2009;69(3):330-4. doi: 10.1080/00365510802588076.

PMID:
19031172
9.

Diagnostic value of salivary cortisol in Cushing's syndrome (CS).

Cardoso EM, Arregger AL, Tumilasci OR, Contreras LN.

Clin Endocrinol (Oxf). 2009 Apr;70(4):516-21. doi: 10.1111/j.1365-2265.2008.03381.x. Epub 2008 Aug 15.

PMID:
18710466
10.

Effect of translocator protein (18 kDa)-ligand binding on neurotransmitter-induced salivary secretion in rat submandibular glands.

Ostuni MA, Tumilasci OR, Péranzi G, Cardoso EM, Contreras LN, Arregger AL, Papadopoulos V, Lacapere JJ.

Biol Cell. 2008 Jul;100(7):427-39. doi: 10.1042/BC20070157.

PMID:
18269350
11.

Salivary testosterone: a reliable approach to the diagnosis of male hypogonadism.

Arregger AL, Contreras LN, Tumilasci OR, Aquilano DR, Cardoso EM.

Clin Endocrinol (Oxf). 2007 Nov;67(5):656-62.

PMID:
17953627
12.

Diagnostic value of salivary cortisol in end stage renal disease.

Arregger AL, Cardoso EM, Tumilasci O, Contreras LN.

Steroids. 2008 Jan;73(1):77-82. Epub 2007 Sep 11.

PMID:
17945323
13.

Standardization of a simple method to study whole saliva: clinical use in different pathologies.

Tumilasci OR, Cardoso EM, Contreras LN, Belforte J, Arregger AL, Ostuni MA.

Acta Odontol Latinoam. 2006;19(2):47-51.

PMID:
17645210
14.

Assessment of adrenal function by measurement of salivary steroids in response to corticotrophin in patients infected with human immunodeficiency virus.

Cardoso E, Persi G, González N, Tumilasci O, Arregger A, Burgos M, Rodríguez V, Molina A, Contreras LN.

Steroids. 2007 Apr;72(4):328-34. Epub 2006 Dec 17.

PMID:
17257634
15.

A new less-invasive and more informative low-dose ACTH test: salivary steroids in response to intramuscular corticotrophin.

Contreras LN, Arregger AL, Persi GG, Gonzalez NS, Cardoso EM.

Clin Endocrinol (Oxf). 2004 Dec;61(6):675-82.

PMID:
15579180
16.

[Detection of preclinical Cushing's syndrome in overweight type 2 diabetic patients].

Contreras LN, Cardoso E, Lozano MP, Pozzo J, Pagano P, Claus-Hermbeg H.

Medicina (B Aires). 2000;60(3):326-30. Spanish.

PMID:
11050809
17.

Glucocorticoids: their role on gonadal function and LH secretion.

Contreras LN, Masini AM, Danna MM, Kral M, Bruno OD, Rossi MA, Andrada JA.

Minerva Endocrinol. 1996 Jun;21(2):43-6.

PMID:
8968148
18.

Adrenal ganglioneuroma-pheochromocytoma secreting vasoactive intestinal polypeptide.

Contreras LN, Budd D, Yen TS, Thomas C, Tyrrell JB.

West J Med. 1991 Mar;154(3):334-7. No abstract available.

19.

Long-term low-dose glucocorticoid therapy in hyperandrogenized women: utility and effects on bone mineral content and hypothalamic-pituitary-adrenocortical function.

Contreras LN, Rizzo L, Gómez RM, Zanchetta JR, Rossi MA, Kral M, Masini AM, Bruno OD.

Horm Res. 1991;35(3-4):142-5.

PMID:
1839628
20.

Diagnosis of Cushing disease.

Bruno OD, Rossi MA, Contreras LN.

Ann Intern Med. 1990 Nov 15;113(10):807. No abstract available.

PMID:
2240889

Supplemental Content

Loading ...
Support Center